We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Impax Eyes July Launch of Generic Concerta Following Patent Treaty With J&J, Alza
Impax Eyes July Launch of Generic Concerta Following Patent Treaty With J&J, Alza
September 17, 2012
Impax Laboratories can market generic versions of Alza Corporation’s attention deficit hyperactivity disorder (ADHD) drug Concerta in 2013 under a settlement with the Johnson & Johnson (J&J) subsidiary.